Drug-induced liver injury (DILI) remains a persistent challenge in drug development, endangering patient safety and delaying the availability of critical therapies. Just days ago, the FDA issued a warning about […] The post Ocaliva, Azelaprag, and the Continuing Challenge of Drug-Induced Liver Injury: A Call for Human-Relevant Models appeared first on Emulate.
